X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (875) 875
Publication (16) 16
Book Chapter (8) 8
Patent (5) 5
Dissertation (1) 1
Newspaper Article (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (337) 337
oncology (316) 316
female (169) 169
male (162) 162
cancer (145) 145
middle aged (144) 144
aged (137) 137
adult (126) 126
colorectal cancer (120) 120
colorectal neoplasms - drug therapy (101) 101
chemotherapy (97) 97
antineoplastic combined chemotherapy protocols - therapeutic use (79) 79
mutation (75) 75
colorectal neoplasms - pathology (69) 69
antineoplastic agents - therapeutic use (68) 68
treatment outcome (68) 68
metastasis (65) 65
care and treatment (62) 62
cetuximab (62) 62
tumors (62) 62
disease-free survival (60) 60
aged, 80 and over (59) 59
colorectal neoplasms - genetics (58) 58
neoplasms - drug therapy (57) 57
survival (57) 57
research (53) 53
patients (52) 52
1st-line treatment (51) 51
clinical trials (49) 49
prognosis (49) 49
fluorouracil (47) 47
oxaliplatin (45) 45
bevacizumab (41) 41
hematology, oncology and palliative medicine (40) 40
neoplasm staging (40) 40
therapy (40) 40
animals (39) 39
biomarkers (39) 39
neoplasm metastasis (39) 39
antineoplastic agents - pharmacology (38) 38
leucovorin (38) 38
antineoplastic combined chemotherapy protocols - adverse effects (36) 36
metastatic colorectal-cancer (34) 34
health aspects (33) 33
analysis (32) 32
kaplan-meier estimate (32) 32
metastases (32) 32
receptor, epidermal growth factor - antagonists & inhibitors (32) 32
colorectal carcinoma (31) 31
mutations (31) 31
antineoplastic combined chemotherapy protocols - administration & dosage (30) 30
fluorouracil - administration & dosage (30) 30
growth-factor receptor (30) 30
irinotecan (30) 30
antineoplastic agents - adverse effects (29) 29
colorectal neoplasms - mortality (29) 29
cancer therapies (28) 28
medical research (28) 28
organoplatinum compounds - administration & dosage (28) 28
drug administration schedule (27) 27
genetic aspects (27) 27
panitumumab (27) 27
dose-response relationship, drug (26) 26
drug therapy (26) 26
expression (26) 26
medicine & public health (26) 26
cell line, tumor (25) 25
leucovorin - administration & dosage (25) 25
maximum tolerated dose (25) 25
survival analysis (25) 25
survival rate (25) 25
young adult (25) 25
antibodies, monoclonal - therapeutic use (24) 24
colon-cancer (24) 24
egfr (24) 24
multidisciplinary sciences (24) 24
proto-oncogene proteins b-raf - genetics (24) 24
ras proteins - genetics (24) 24
antibodies, monoclonal - administration & dosage (23) 23
deoxycytidine - analogs & derivatives (23) 23
acquired-resistance (22) 22
adenocarcinoma - drug therapy (22) 22
antineoplastic agents - administration & dosage (22) 22
breast-cancer (22) 22
combination (22) 22
deoxycytidine - administration & dosage (22) 22
open-label (22) 22
cetuximab plus irinotecan (21) 21
colorectal-cancer (21) 21
genomics (21) 21
molecular targeted therapy (21) 21
pharmacology & pharmacy (21) 21
proto-oncogene proteins - genetics (21) 21
proto-oncogene proteins p21 (21) 21
signal transduction - drug effects (21) 21
camptothecin - analogs & derivatives (20) 20
chemotherapy, adjuvant (20) 20
clinical trials as topic (20) 20
kras (20) 20
medicine (20) 20
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 7, p. e103634
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 10, pp. 1386 - 1395
Journal Article
Annals of oncology, ISSN 0923-7534, 10/2018, Volume 29, pp. vii9 - vii9
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 11, pp. 1023 - 1034
Patients who have colorectal cancer with RAS mutations in exon 2 are unlikely to respond to EGFR blockers. A retrospective analysis of tumors containing other,... 
SURVIVAL | 1ST-LINE TREATMENT | LUNG-CANCER | MEDICINE, GENERAL & INTERNAL | LEUCOVORIN | RANDOMIZED PHASE-III | CETUXIMAB PLUS IRINOTECAN | BRAF | KRAS CODON 12 | FLUOROURACIL | CHEMOTHERAPY | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Membrane Proteins - genetics | Colorectal Neoplasms - genetics | Humans | Antibodies, Monoclonal - therapeutic use | Proto-Oncogene Proteins - genetics | Disease-Free Survival | Fluorouracil - therapeutic use | Neoplasm Metastasis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | GTP Phosphohydrolases - genetics | Proto-Oncogene Proteins B-raf - genetics | Colorectal Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Leucovorin - therapeutic use | Mutation | Colorectal Neoplasms - pathology | Genes, ras | Organoplatinum Compounds - therapeutic use | Care and treatment | Dosage and administration | Research | Gene mutations | Panitumumab | Colorectal cancer | Hypothesis testing | Medical research | Statistical analysis | Epidermal growth factor receptors | Colorectal carcinoma | Metastasis | Cancer therapies | Survival | Patients | Metastases | Studies | Hypotheses | Chemotherapy | Epidermal growth factor | Oxaliplatin | Testing laboratories | Medical prognosis | Biomarkers | Deoxyribonucleic acid--DNA | Tumors
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 5, pp. 499 - 508
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2014, Volume 383, Issue 9911, pp. 31 - 39
Journal Article
Journal Article
Nature (London), ISSN 0028-0836, 08/2017, Volume 548, Issue 7665, pp. 40 - 41
Dienstmann and Tabernero cite that progress is being made in the use of personalized approaches to create both in vitro and in vivo tumor models that could be... 
Drugs | Medical research | Genomics | Genes | Clinical trials | Metastasis | Drug screening | Cancer therapies | Patients | Gene sequencing | Anticancer properties | Cell growth | Precision medicine | In vivo methods and tests | In vitro methods and tests | Deoxyribonucleic acid--DNA | Tumors | DNA sequencing | Cancer
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 937 - 948
Summary Background Tumour mutational status is an important determinant of the response of metastatic colorectal cancer to targeted treatments. However, the... 
Hematology, Oncology and Palliative Medicine | KRAS MUTATIONS | 1ST-LINE TREATMENT | LEUCOVORIN | PLUS IRINOTECAN | ONCOLOGY | RANDOMIZED PHASE-III | INHIBITS GROWTH | ACQUIRED-RESISTANCE | FLUOROURACIL | PLACEBO PLUS | TUMOR-GROWTH | Predictive Value of Tests | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Clinical Trials, Phase III as Topic | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Real-Time Polymerase Chain Reaction | Precision Medicine | Receptor, TIE-1 - blood | Phosphatidylinositol 3-Kinases - blood | Genetic Predisposition to Disease | Adenocarcinoma - blood | ras Proteins - blood | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease Progression | Phenotype | Class I Phosphatidylinositol 3-Kinases | Biomarkers, Tumor - genetics | ras Proteins - genetics | Patient Selection | DNA, Neoplasm - blood | Female | Adenocarcinoma - genetics | Retrospective Studies | Pyridines - therapeutic use | Colorectal Neoplasms - mortality | Colorectal Neoplasms - blood | Kaplan-Meier Estimate | Proportional Hazards Models | Phenylurea Compounds - therapeutic use | Proto-Oncogene Proteins B-raf - blood | Proto-Oncogene Proteins - genetics | Treatment Outcome | Randomized Controlled Trials as Topic | Biomarkers, Tumor - blood | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Proto-Oncogene Proteins B-raf - genetics | Aged | DNA, Neoplasm - genetics | Colorectal Neoplasms - pathology | Proto-Oncogene Proteins - blood | Adenocarcinoma - mortality | Medical colleges | Medical research | Cancer patients | Prognosis | Liver | DNA | Colorectal cancer | Genetic research | Medicine, Experimental | Metastasis | Life Sciences | Human health and pathology
Journal Article